this effect results from a broad range of effects on appetite, weight, palatability, and the reward-seeking pathway in the central nervous system
Some patients breeze through this phase with minimal discomfort, while others find it more challenging
Dose Escalation Timing and Tolerability Adjustments Standard protocol advances dosing every 4 weeks, allowing the body to adapt
When a GLP-1 receptor agonist like semaglutide crosses the blood-brain barrier and binds to receptors in these reward centers, it appears to dampen the dopamine surge associated with alcohol consumption
Most established patients from these areas alternate between an in-person visit at Carrollwood for labs and dose changes and a Florida telehealth follow-up in between, once the medication and dose are stable and tolerated
Synthetic GLP-1 agonists activate GLP-1 receptors in the pancreas , increasing cyclic adenosine monophosphate (cAMP)